Full name
CEFARM "B" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,4 | -0,5 | -0,6 | -2,2 |
Gross profit (loss) | -0,5 | -0,8 | -1 | -33 |
EBITDA | -0,4 | -0,6 | -0,7 | -28,3 |
Short time liabilities | 2,6 | 3,4 | 4,6 | 35,1 |
Other operating costs | 0,1 | 0,1 | 0,2 | 142,1 |
Equity capital | -1,2 | -1,9 | -2,9 | -53 |
Operating profit (EBIT) | -0,5 | -0,6 | -0,8 | -23,8 |
Assets | 1,5 | 1,6 | 1,8 | 10,5 |
Net profit (loss) | -0,5 | -0,8 | -1 | -33 |
Cash | 0 | 0 | 0 | -5,1 |
Net income from sale | 6,6 | 7,6 | 9,4 | 23 |
Liabilities and provisions for liabilities | 2,7 | 3,5 | 4,7 | 33,5 |
Working assets | 1,2 | 1,4 | 1,5 | 12,5 |
Other income costs | 0,1 | 0 | 0 | -44,3 |
Depreciation | 0,1 | 0,1 | 0,1 | -16,2 |
% | % | % | p.p. | |
Profitability of capital | 47,4 | 39,9 | 34,7 | -5,2 |
Equity capital to total assets | -76,1 | -118,5 | -164,1 | -45,6 |
Gross profit margin | -8,3 | -10 | -10,9 | -0,9 |
EBITDA Margin | -6,6 | -7,3 | -7,6 | -0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 144 | 163 | 179 | 16 |
Current financial liquidity indicator | 0.4655267000198364 | 0.3981706202030182 | 0.3316873013973236 | -0,1 |
Net dept to EBITDA | 0.04052726551890373 | 0.036829374730587006 | 0.02724728360772133 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane